Evidence map›Paper›PMID 31660334›Full record

ArticleOpen forum infectious diseases2019

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), and HIV/HCV Coinfection.

Jennifer S Hanberg, Matthew S Freiberg, Matthew B Goetz, Maria C Rodriguez-Barradas, Cynthia Gibert, Kris Ann Oursler, Amy C Justice, Janet P Tate, VACS Project Team

Open access · greenAbstract read
In one paragraph

Article in Open forum infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Jennifer S HanbergDepartment of Medicine, Yale University School of Medicine, New Haven, Connecticut.
Matthew S FreibergDepartment of Medicine and Epidemiology, Vanderbilt University School of Medicine, Nashville, Tennessee.
Matthew B GoetzDivision of Infectious Diseases, University of California, David Geffen School of Medicine, Los Angeles.
Maria C Rodriguez-BarradasDepartment of Medicine and Infectious Disease, Baylor College of Medicine, Houston, Texas.
Cynthia GibertDivision of Infectious Diseases and Medicine, George Washington University, School of Medicine and Health Sciences, Washington, District of Columbia.
Kris Ann OurslerDepartment of Medicine, Virginia Tech Carilion School of Medicine, Salem.
Amy C JusticeDepartment of Medicine, Yale University School of Medicine, New Haven, Connecticut.ORCID 0000-0003-0139-5502
Janet P TateDepartment of Medicine, Yale University School of Medicine, New Haven, Connecticut.
VACS Project Team
VA Connecticut Healthcare System · USBaylor College of Medicine · USGeorge Washington University · USUniversity of California, Los Angeles · USUniversity of Maryland, Baltimore · USVanderbilt University · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Alcohol Associated Outcomes Among HIV+/- Aging VeteransU10AA013566 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2006 to 2010
$12.7M
Short-Term Reserch Training: Students in Health SchoolsT35HL007649 · NHLBI · YALE UNIVERSITY · PI Sarwat I Chaudhry, Erica L Herzog · 1987 to 2026
$5.7M
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS T35 HL007649NIAAA NIH HHS U10 AA013566
6 · The paper itself

Abstract

backgroundInflammation in human immunodeficiency virus (HIV)-infected patients is associated with poorer health outcomes. Whether inflammation as measured by the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) adds information to existing prognostic indices is not known.

methodsWe analyzed data from 2000 to 2012 in the Veterans Aging Cohort Study (VACS), overall and stratified by HIV/hepatitis C virus status (n = 89 786). We randomly selected a visit date at which all laboratory values of interest were available within 180 days; participants with HIV received at least 1 year of antiretroviral therapy. We followed patients for (1) mortality and (2) hepatic decompensation (HD) and analyzed associations using Cox regression, adjusted for a validated mortality risk index (VACS Index 2.0). In VACS Biomarker Cohort, we considered correlation with biomarkers of inflammation: interleukin-6, D-dimer, and soluble CD-14.

resultsNeutrophil-to-lymphocyte ratio and PLR demonstrated strong unadjusted associations with mortality (

conclusionsNeutrophil-to-lymphocyte ratio and PLR were strongly associated with mortality and HD and weakly correlated with inflammatory biomarkers. However, most of their association was explained by VACS Index 2.0. Addition of NLR and PLR to VACS 2.0 did not substantially improve discrimination for either outcome.

Indexed as

HCVhepatic decompensationinflammationNLRPLR

Identifiers

PMID31660334
PMCPMC6786514
OpenAlexW2985403291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.